US Stock Futures Hold Steady as Soft Inflation Data Eases Fed Rate Hike Fears 
Asian Currencies Stay Rangebound as Middle East Tensions, Weak China GDP Weigh on Sentiment 
US Inflation Expected to Ease in June, but Fed Rate Hike Risks Persist Amid Middle East Tensions 
China Q2 2026 GDP Misses Forecast as Weak Domestic Demand Offsets Export Strength 
South Korea’s KOSPI Triggers Trading Curb as AI Chip Stock Selloff Deepens 
Gold Price Holds Near Record High as Cooling U.S. Inflation Offsets Fed Caution 
Dollar Slides as Softer US Inflation Dims Fed Rate Hike Expectations 
Japanese Yen Holds Steady as Intervention Hopes Grow Ahead of U.S. CPI Data 
European Stocks Slip as Middle East Tensions and Hormuz Threat Rattle Markets 
Singapore GDP Grows 5.7% in Q2 2026 as AI-Driven Manufacturing Boosts Economy 
Dollar Holds Steady Ahead of U.S. CPI as Oil Surge, Middle East Tensions Keep Markets on Edge 
South Korea Raises Interest Rates to 2.75% as Inflation and Weak Won Drive Tightening 
Oil Prices Climb as Trump Escalates Iran Pressure, Strait of Hormuz Risks Grow 
Dollar Eases as Middle East Conflict, Fed Outlook and Japan Pension Policy Drive FX Markets 
Asian Stocks Slide as Oil Surge, U.S.-Iran Tensions and Fed Rate Bets Weigh on Markets 
Port of Los Angeles Posts Record June Cargo Volume as Importers Rush Ahead of U.S. Tariffs 
With zero-duty treatment for flagship products including gems and diamonds, generic drugs, and certain aircraft parts, the new US–India interim trade agreement reduces US tariffs on Indian products from roughly 25% (close 50% effective with punitive levies) to 18%. India promises to raise US imports by USD 500 billion over five years in return, and promises better Indian auto parts access in return for reduced tariffs on American industrial and agricultural products like tree nuts and soybean oil. All things considered, the package redefines a tense tariff scenario beyond 2025, therefore giving Indian exporters renewed pricing power and stability in their most important market.
Following the tariff shock of 2025, zero-duty access re-establishes competitiveness for Surat's diamond polishing and export cluster; jewels and jewellery become front-line champions. Listed companies such Goldiam International and Rajesh Exports have already shown significant stock gains (around 5–20%) on expectation of greater US income; diversified jewellery giants like Titan and Kalyan Jewellers also stand to profit from export-led development. With the 18% tariff limit boosting margins and demand for clothing and shoe exporters such Indo Count, Gokaldas Exports, and Mirza International in their main US markets, textiles and leather follow closely behind.
As zero tariffs on generics and essential ingredients strengthen India's position as the leading supplier to the US under a more fluid Section 232 review and regulatory environment, drugs obtain a structural advantage; Sun Pharma, Dr. Reddy's, and Cipla are set for volume increase. Ancillary industries are also boosted: aircraft and automotive components exemptions support companies including Bharat Forge and Hindustan Aeronautics, whereas chemical and plastics exporters profit from the lowered 18% rate. While politically sensitive industries such dairy and FMCG (e.g., Hatsun Agro) remain shielded from a surge of US imports, keeping local markets fairly insulated, tech and data-center participants like Netweb and E2E Networks may ride growing GPU and trade flows.
